Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection.
Corsini CA, Filgueiras PS, Almeida NB, Miranda DA, Gomes SV, Lourenço AJ, Bicalho CM, Assis JV, Amorim RN, Silva RA, Vilela RV, Lima TM, Abreu DP, Alvim RG, Castilho LR, Martins-Filho OA, Otta DA, Grenfell RF. Corsini CA, et al. Among authors: bicalho cm. Sci Rep. 2023 Oct 30;13(1):18606. doi: 10.1038/s41598-023-43263-y. Sci Rep. 2023. PMID: 37903875 Free PMC article.
Rapid antigen test as a tool for the identification of SARS-CoV-2 infection and its potential as a self-testing device.
Filgueiras PS, Corsini CA, Almeida NBF, Pedrosa MLC, Miranda DAP, Gomes SVC, Assis JV, Silva RA, Medeiros MIVARC, Lourenço AJ, Bicalho CMF, Vilela RVR, Jeremias WJ, Fernandes GDR, Queiroz RFGE. Filgueiras PS, et al. Among authors: bicalho cmf. Rev Soc Bras Med Trop. 2023 May 22;56:e01672022. doi: 10.1590/0037-8682-0167-2022. eCollection 2023. Rev Soc Bras Med Trop. 2023. PMID: 37222349 Free PMC article.
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Grenfell RFQ, et al. Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022. Front Immunol. 2022. PMID: 35757764 Free PMC article. Clinical Trial.